Controlled release systems of angiogenic growth factors for cardiovascular diseases (Q36985904)

17 August 2017

1 reference

title

Controlled release systems of angiogenic growth factors for cardiovascular diseases (English)

1 reference

17 August 2017

cardiovascular disease

1 reference

Jiro Esaki

1

1 reference

17 August 2017

Akira Marui

series ordinal

2

1 reference

17 August 2017

Yasuhiko Tabata

series ordinal

3

1 reference

17 August 2017

Masashi Komeda

series ordinal

4

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 November 2007

1 reference

Expert Opinion on Drug Delivery

17 August 2017

1 reference

17 August 2017

4

1 reference

17 August 2017

6

1 reference

17 August 2017

635-649

1 reference

Endothelial progenitor cells: characterization and role in vascular biology

17 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Mechanisms of angiogenesis and arteriogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Angiogenesis and arteriogenesis in limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

The biology of VEGF and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Endothelial progenitor cells for postnatal vasculogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Fibroblast growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Hepatocyte growth factor: from diagnosis to clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

The clinical toxicity profile of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) targeting angiogenesis inhibitors; a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Fibroblast growth factors, their receptors and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Molecular targets for retinal vascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Molecular regulation of vessel maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors: role of the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Gene transfer into rabbit arteries with adeno-associated virus and adenovirus vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Gene therapy death prompts review of adenovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Safety and Feasibility of Catheter-Based Local Intracoronary Vascular Endothelial Growth Factor Gene Transfer in the Prevention of Postangioplasty and In-Stent Restenosis and in the Treatment of Chronic Myocardial Ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermitt

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Protein release from gelatin matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Tissue Regeneration Based on Growth Factor Release

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Controlled and modulated release of basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Toward surgical angiogenesis using slow-released basic fibroblast growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Development of biologic coronary artery bypass grafting in a rabbit model: revival of a classic concept with modern biotechnology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

A combination of omental flap and growth factor therapy induces arteriogenesis and increases myocardial perfusion in chronic myocardial ischemia: evolving concept of biologic coronary artery bypass grafting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Enhanced angiogenesis by gelatin hydrogels incorporating basic fibroblast growth factor in rabbit model of hind limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Simultaneous application of basic fibroblast growth factor and hepatocyte growth factor to enhance the blood vessels formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

A novel approach to therapeutic angiogenesis for patients with critical limb ischemia by sustained release of basic fibroblast growth factor using biodegradable gelatin hydrogel: an initial report of the phase I-IIa study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Age-dependent impairment of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.6.635

21 January 2018

Identifiers

DOI

10.1517/17425247.4.6.635

1 reference

17 August 2017

1 reference